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Abstract. We tested the influence of the apolipoprotein E 
(apoE) polymorphism on the intrapair differences in the 
levels of plasma cholesterol, plasma triglycerides, low 
density lipoprotein-cholesterol, apoB and apoE in mono- 
zygotic (MZ) twins, and estimated whether or not there 
was a interaction between the apoE polymorphism and en- 
vironmental factors. In 65 MZ twin pairs, the intrapair dif- 
ferences in the measured lipoprotein parameters were sim- 
ilar in the different apoE phenotype classes. This indicates 
that the effect of the apoE polymorphism is not influenced 
by environmental variability between the MZ pair mem- 
bers and accordingly identifies the APOE gene as a 
"level" gene. 
Introduction 
Apolipoprotein E (apoE) is one of the major protein con- 
stituents of chylomicron and very low density lipoprotein 
(VLDL) remnants. It plays a central role in the receptor- 
mediated uptake of these particles by acting as a high 
affinity ligand for hepatic lipoprotein receptors (Sherril et 
al. 1980; Weisgraber et al. 1982). ApoE also plays a key 
role in the conversion of VLDL via intermediate density 
lipoprotein (IDL) into low density lipoproteins (LDL) 
(Demant et al. 1991). Human apoE can be separated by 
isoelectric focusing into three major isoforms, E2, E3 and 
E4, which each differ in their isoelectric point by a single 
charge unit, apoE4 being the most basic and E2 the most 
acidic form. These isoforms are encoded by three codom- 
inant alleles. E*2, E*3 and E*4, at a single APOE gene lo- 
cus on chromosome 19 (Zannis and Breslow 1981; Scott 
et al. 1985). ApoE3 is the most common isoform. ApoE4 
differs from apoE3 by an arginine for cysteine substitu- 
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tion at amino acid residue 112 [designated as apoE4 
(Cys 112-+Arg)J, whereas apoE2 differs from apoE3 by a 
cysteine for arginine substitution at residue 158 [apo 
E2(Arg158--)Cys)]. Various population studies have 
demonstrated an influence of the apoE polymorphism on 
plasma lipid and (apo)lipoprotein levels (reviewed by 
Davignon et al. 1988). In these studies, the APOE*2 allele 
is associated with lower levels of total plasma cholesterol, 
LDL cholesterol and apoB, whereas for the APOE*4 al- 
lele, the opposite holds true. The apoE polymorphism was 
found to explain between 1.4% and 8.7% of the interindi- 
vidual variability of plasma cholesterol (Smit et al. 1988; 
Boerwinkle and Utermann 1988). 
There are a number of reports showing an interaction 
between the apoE polymorphism and environmental fac- 
tors (e.g. diet) in their effect on lipids and (apo)lipopro- 
teins (for recent reviews on this, see Abbey et al. 1991; 
Ferrel 1992). An approach that can be used to study this 
interaction is that based on studying monozygotic (MZ) 
twin pairs, as outlined by Magnus et al. (1981) and Berg 
(1984, 1987, 1990). MZ twins share all nuclear genes; 
thus, the difference in a quantitative trait, e.g. plasma cho- 
lesterol, observed between the two members of an MZ 
twin pair must reflect variation caused by the environ- 
ment, such as diet. In order to study the effect of the apoE 
polymorphism, we have grouped MZ twin pairs according 
to apoE phenotypes. This makes it possible to determine 
whether agroup of MZ twins with a specific apoE pheno- 
type has a significantly larger or smaller mean [absolutel 
intrapair difference in plasma cholesterol than other 
groups of MZ pairs with other apoE phenotypes. The find- 
ing of a significant and consistent effect would imply the 
existence of an interaction between the APOE gene and 
environmental factors. Accordingly, in the present study, 
we estimated the influence of the apoE polymorphism on 
the intrapair differences of plasma lipids in 65 MZ twin 
pairs, as part of a study of 160 Dutch twin families. 
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Materials and methods 
Population description and sample collection 
The individuals described in this article were apparently healthy, and 
belonged to a cohort of 160 twin families (158 fathers, mean age 48.1 
years, SD = 6.7; 160 mothers, mean age 45.6 years, SD -- 5.9; 161 
boys, mean age 16.7 years, SD = 1.8; 159 girls, mean age 16.7 years, 
SD = 2.2). All twins were still living with their parents. The addresses 
of the families were obtained from various City Council population 
registries. Families were only included in this study if both parents 
and twins were willing to cooperate. There were 35 families with MZ 
boys, 35 with MZ girls, 31 with dizygous (DZ) boys, 30 with DZ girls 
and 29 with DZ twins of opposite sex. 
EDTA blood was obtained between 8.30 and 10.30 a.m. by 
venepuncture after overnight fasting. Plasma was separated from the 
cells by centrifugation for 10min at 3000rpm. Part of the plasma was 
kept at 4~ for lipid determinations within the next 5 days. The re- 
mainder was stored in 2.5 ml aliquots in tubes with tightly fitting 
screw-caps at -20~ for later use. 
Plasma lipid and (apo)lipoprotein analysis 
Cholesterol and triglyceride l vels were determined using enzymatic 
methods (Boehringer, Mannheim, Germany; CHOD-PAP kit no. 
236691 and GPO-PAP kit no. 701904). HDL cholesterol was mea- 
sured following phosphotungstate Mg 2+ precipitation of VLDL, IDL 
and LDL according to Lopes-Virella et al. (1977). LDL cholesterol 
was subsequently calculated using the formula of Friedewald et al. 
(1972). 
Apolipoprotein B was quantified by radial immunodiffusion as de- 
scribed by ttavekes et al. (1981). ApoE was quantified by enzyme- 
linked immunosorbent assays as described by Bury et al. (1986). 
Apolipoprotein E phenotyping 
The apoE phenotyping was performed using a rapid micromethod 
based on isoelectric focusing (pH 5-7) of delipidated plasma samples, 
followed by immunoblotting on nitrocellulose filters using a poly- 
clonal anti-apoE antiserum as previously described (Havekes et al. 
1987). 
Statistical analysis 
The apoE phenotype frequencies and the APOE allele frequencies 
were determined in the complete set of 160 families with the excep- 
tion of 2 missing fathers. For the parents and MZ twins, the calcula- 
tion of the allele frequencies was performed by gene-counting proce- 
dures. For the DZ twins, the allele frequencies were estimated accord- 
ing to Martin (1975) using the sib-genotype frequencies of Smith and 
Penrose (1955). 
The MZ intrapair differences were estimated in three different 
groups: MZ twin pairs with the E3E2 phenotype (n--12), MZ pairs 
with the E3E3 phenotype (n=39) and MZ pairs with the E4E3 pheno- 
type (n = 14). The one MZ pair with the E4E4 phenotype was excluded 
from these analyses for obvious reasons. We did not observe MZ twin 
pairs with the E2E2 or the E4E2 phenotypes. The phenotypic differ- 
ence for each twin pair was calculated as: df(g) = Yef~ - Ygf2 where the 
subscriptfdenotes hetwin pair, g denotes genotype, and ! and 2 de- 
note the first and second twin in the pair with arbitrary labelling. A 
two-way analysis of variance (ANOVA), with gender and apoE phe- 
notype ntered as factors, was then computed for three different esti- 
mates of xf~g): (1) calculated according to Magnus et al. (1981) as Xf(g) 
= I df(g)[, (2) calculated according to Elashoff et al. (1991) as Xf(g) = 
[dftg), - Cg ...... I, where Cg denotes the mean genotype-specific differ- 
ence, and (3) again according to Elashoff et al. (1991 ), as Xf(g) = I dry.e) 
- c8 ,,eai,,, P,where cg denotes the median genotype-specific d fference. 
In addition, we also followed the approach proposed by Martin et al. 
(1983) by calculating within-pairs mean squares (WMS) for each 
trait, followed by a comparison of the WMS for each apoE phenotype 
by means of Bartlett's test of heterogeneity of variances (Sokal and 
Rohlf 1981 ). ANOVA procedures were performed using the programs 
contained inthe statistical package NCSS, version 5.1 (Dr. J. L. Hinze, 
Kaysville, Utah, USA). 
Table 1. Apolipoprotein E phenotype numbers, relative frequencies 
(in %, in brackets) and apoE allele frequencies inparents and children 
of 160 Dutch twin families 
ApoE Parents Twins 
phenotype 
MZ a DZ b 
E2E2 3 (0.9) 0 (0.0) 1 (0.6) 
E3E2 48 (15.0) 13 (18.6) 37 (20.6) 
E3E3 185 (57.8) 41 (58.6) 88 (48.9) 
E4E2 10 (3.1) 0 (0.0) 4 (2.2) 
E4E3 67 (20.9) 15 (21.4) 46 (25.6) 
E4E4 5 (1.6) 1 (1.4) 4 (2.2) 
Total 318 70 180 
Alleles: 
E*2 0.101 0.093 0.103 
E*3 0.762 0.786 0.726 
E*4 0.137 0.121 0.163 
a Each MZ twin pair is counted as one phenotype 
b Each DZ twin pair is counted as two phenotypes; for this group, the 
allele frequencies are calculated from sib-pair phenotype frequencies 
according to Martin (1975) 
Results 
Apolipoprotein E phenotype distribution 
The apoE phenotype numbers  and frequencies for the 
complete set of  parents and twins are presented in Table 1. 
The observed apoE frequencies in all groups consideres, 
viz. parents, MZ and DZ twins, were in genetic equi l ib-  
r ium (results not shown). The observed allele frequencies 
in these three groups do not differ s ignif icantly f rom those 
found in a larger Dutch populat ion  (Smit  et al. 1988). 
There were no s ignif icant gender differences with respect 
to the apoE phenotype distr ibut ion in the three groups 
considered (results not shown). 
Influence of  apoE polymorphism on intrapair difference 
in measured parameters in MZ twins 
The inf luence of  the apoE po lymorph ism on the p lasma 
l ipid levels was est imated by compar ing the intrapair dif- 
ferences in the levels of the quantitat ive traits in the MZ 
twins, init ial ly as out l ined by Magnus  et al. (1981). As ex- 
p la ined above, we only considered the MZ twin-pairs with 
the E3E2, E3E3 or E4E3 phenotypes.  As shown in Table 
2, the mean apoE phenotype-speci f ic  intrapair differences 
for each of the traits, est imated by xf~g) = I df(g)] (see statisti- 
cal analysis for further details), did not differ signif icantly. 
However,  since it was reported that this approach could 
result in Type I or Type II errors (Browne and Forsythe 
1974), we repeated our calculat ions, fo l lowing the sugges- 
t ions of  E lashoff  et al. (1991), us ing a Levene test. This in- 
volves the subtract ion of  a measure of  central tendency 
f rom the phenotypic  dif ference for each twin pair (see sta- 
tistical analysis for further details). We considered two 
different est imates of central tendency Cg, with Cg repre- 
senting either the mean genotype-speci f ic  di f ference or 
the median  genotype-speci f ic  difference. However,  as can 
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Table 2. ApoE genotype-specific mean within-pair differences (XI(~)) • 
SD estimated by three different methods for MZ 
ApoE phenotype P" 
E3E2 E3E3 E4E3 
(n = 12) (n = 39) (n = 14) 
Xfe) + SD XAr • SD XfT~) -+ SD 
X/<~) = I dm,,) l  
Cholesterol b 0.45 • 0.31 0.37 • 0.31 0.26 • 0.30 NS 
Triglycerides 0.25 • 0.14 0.12 • 0.19 0.18 • 0.15 NS 
LDL-cholesterol 0.38 +_ 0.28 0.31 • 0.25 0.26 _+ 0.26 NS 
ApoB 10.2 • 6.6 • 5.9 • NS 
ApoE I.I • 1.0 1.0 • 0.8 _+0.8 NS 
_r.lr,,,; = I d/(,,,,) - mean d17~, ) I 
Cholesterol b 0.38 • 0.28 0.36 • 0.25 0.25 • 0.26 NS 
Triglycerides 0.23-+0.14 0.11 +_0.12 0.17• NS 
LDL-cholesterol 0.36 • 0.24 0.31 • 0.25 0.24 • 0.30 NS 
ApoB 9.7 • 6.6 • 6.3 • l NS 
ApoE 1.1 • 1.0 • 0.8 _+0,7 NS 
x l~.  ~ = Idle:,, ) - med ian  dl(,~)l 
Cholesterol b 0.38 _+ 0.28 0.36 • 0.31 0.25 • 0.30 NS 
Triglycerides 0.23_+0.14 0.11 • 0.17 • 0.15 NS 
LDL cholesterol 0.35 • 0.24 0.31 • 0.25 0.24 +_ 0.26 NS 
ApoB 9.5 • 7.3 6.6 • 5.8 • NS 
ApoE I.I • 1.0 1.0 _+0.6 0.8 • NS 
NS, not significant (P > 0.05) 
P value indicating the difference between the apoE phenotpye groups 
calculated by means of two-way ANOVA with apoE phenotye and 
gender entered as factors 
b Levels are expressed inmmol/l except for the apoB and apoE levels, 
which are expressed in mg/100 ml 
Table 3. Within-pairs mean squares (WMS) by apoE phenotype for 
levels of plasma lipids and (apo)lipoproteins  MZ twins 
E3E2 E3E3 E4E3 Z 2~ 
(n= 12) (n = 39) (n= 14) 
Cholesterol 0.33 0.23 0.10 4.01 
Triglycerides 0.09 0.04 0.06 4.77 
LDL cholesterol 0.26 0.16 0.10 2.73 
ApoB 189.30 76. l 0 115.20 4.06 
ApoE 2.09 1.87 0.84 2.92 
X 2 and its significance were calculated by means of Bartlett's test of 
heterogeneity of variances. The level of Z 2 is significant larger than 
5.99 (with df= 2) 
be inferred from Table 2, this did not result in a drastic 
change in the phenotype-specific mean intrapair differ- 
ences. For each of the traits, these models did not reveal 
any significant difference between the three apoE pheno- 
type groups, as evaluated by two-way ANOVA. In addi- 
tion, there was (1) no significant influence of gender on 
the within-pair differences, and (2) no significant interac- 
tion between apoE phenotype and gender (results not 
shown). We also followed a different approach, suggested 
by Martin et al. (1983), and used the WMS as an estimate 
for the intrapair difference. However, this approach also 
did not result in any significant apoE phenotype-specific 
mean intrapair difl%rence (Table 3). Altogether, our results 
indicate that, in the MZ twins that we studied, no signifi- 
cant interaction between environmental variability and 
apoE phenotype lbr any of the lipid traits considered could 
be detected. 
Discuss ion  
In the present study, we describe the apoE phenotype dis- 
tribution and APOE allele frequencies for the parents, and 
MZ and DZ twins from 160 Dutch twin families. The 
apoE phenotype distribution and APOE allele frequencies 
in each of the three groups were comparable with the val- 
ues reported previously for a large Dutch population (Smit 
et al. 1988). 
In various studies, the apoE polymorphism has been re- 
ported to influence plasma lipid and (apo)lipoprotein lev- 
els, although to a variable extent (Davignon et al. 1988). 
The APOE*4 allele was found to be associated with in- 
creased levels of total plasma cholesterol, LDL choles- 
terol, apoB and recently also with increased levels of 
Lp(a) (de Knijff et al. 1991), whereas the opposite holds 
true for the APOE*2 allele. Conversely, in APOE*4 allele 
carriers, plasma apoE levels were decreased, whereas the 
apoE levels were increased in APOE*2 allele carriers. The 
mechanism behind the effect of the apoE polymorphism 
on plasma (apo)lipoprotein levels is commonly assumed 
to be the result of the influence of the apoE polymorphism 
on the efficiency of the catabolism of chylomicron and 
VLDL remnants (Utermann 1985; Weintraub et al. 1987; 
Demant et al. 1991). These influences were also found by 
us for this group of twin families (Kempen et al. 199 l ). 
Several studies have provided evidence t%r a significant 
interaction between environmental (e.g. dietary) variabil- 
ity and apoE polymorphism (Miettinen et al. 1988, 1992; 
Tikkanen et al. 1990a; Manttari et al. 1991). These studies 
demonstrate that individuals carrying an APOE*4 allele 
show a greater sensitivity for dietary interventions when 
compared with individuals without this allele. This inter- 
action could, at least partly, be explained by differences in 
intestinal cholesterol absorption and cholesterol synthesis 
(Miettinen 1991; Miettinen et al. 1992). However, simi- 
larly convincing studies have failed to detect any interac- 
tion between the apoE polymorphism and dietary variabil- 
ity (Fisher et al. 1983; Savolainen et al. 1991; Glatz et al. 
1991 ). Furthermore, Hallman et al, (1991 ) showed that the 
influence of the apoE polymorphism on plasma choles- 
terol levels in nine different populations was remarkable 
consistent, despite marked differences in apoE phenotype 
frequencies and dietary habits between the various popu- 
lations. This suggests that the APOE gene influences the 
plasma cholesterol levels independent of environmental 
factors. 
We speculate that these conflicting results can be, at 
least in part, explained by the presence of genetic differ- 
ences between the various population. This could give rise 
to gene-gene and gene-environment i eractions to a vari- 
able extent in these populations of unrelated individuals. 
In two studies, Pedersen and Berg (1989, 1990) reported 
an interaction between the PvuI I  restriction fragment 
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length po lymorphism (RFLP) at the LDL receptor locus 
and apoE in two Norwegian populations. They found that 
the increased plasma cholesterol and LDL cholesterol lev- 
els associated with apoE4 are reduced, by an unknown 
mechanism, in those individuals with the PvuII-A1 allele. 
Conversely, in a Finish population, the raised LDL choles- 
terol levels in individuals with apoE4 are further increased 
by the X*2 allele of the Xbal RFLP in the APOB gene 
(Aalto-Set~il~i et al. 1988; Miett inen 1991). In addition, 
there are studies suggesting that genetic variabi l i ty in the 
APOB gene interacts with dietary variabi l ity (Tikkanen et 
al. 1990b; Abbey et al. 1991). 
Instead of  studying associations in randomly selected 
populations of unrelated individuals, Magnus et al. (1981) 
were the first to suggest he use of  mean genotypic intra- 
pair differences, est imated in MZ twin pairs, as a means of  
examining ene-environment i eractions without the dis- 
turbing effects of gene-gene interactions (MZ twins share 
by definition the same nuclear genes). Using this ap- 
proach, Berg (1987) showed, for example, a significant 
interaction between environmental  variabi l i ty and the 
APOB gene on the plasma levels of  apoB. The results of 
the present study indicate that the intrapair differences in 
the group of  MZ twins were not signif icantly different be- 
tween the three apoE phenotype groups (Table 2). How- 
ever, since absolute differences can have highly skewed 
distributions and this, in its turn, can affect both type I and 
Type II errors in subsequently performed tests (Browne 
and Forsythe 1974), we calculated our results as proposed 
by Martin et al. (1983) and Elashoff  et al. (1991). This re- 
suited in similar results, sustaining our initial observa- 
tions, and indicated that the influence of  the APOE gene 
on plasma l ipids is not affected by environmental variabil-  
ity. This identif ies the APOE gene as a "level" gene ac- 
cording to the definit ions proposed by Magnus et al. 
(1981) and Berg (1984, 1987, 1990). 
The twins that we studied were young and still l iving 
with their parents. As was pointed out by Magnus et al. 
(1981), intrapair difference may be more pronounced in 
older twins or in twins not l iving together. Likewise, 
higher intrapair differences can be expected between 
twins l iving separately. Some evidence for this was pub- 
l ished by Koskenvuo et al. (1989). They showed that apoE 
phenotype-specif ic  mean intrapair differences were ap- 
proximately twice as high in MZ twins reared apart when 
compared with the differences in MZ twins l iving to- 
gether. Therefore, we have recently started a second study 
among older twins not l iving together, al lowing for maxi- 
mum environmental  variability. 
In summary, our results indicate that, in our sample of  
adolescent MZ twins, the APOE gene acts as a "level" 
gene, i.e. a gene with an direct influence on plasma lipid 
and (apo)l ipoprotein levels. This supports the hypothesis 
that the apoE polymorphism plays an important and inde- 
pendent role in determining plasma lipid levels. 
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